1.    Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207-14. https://doi.org/10.1038/nature11234.
2.    Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SSK, McCulle SL, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A. 2011;108 Suppl 1:4680-7. https://doi.org/10.1073/pnas.1002611107.
3.    O’Hanlon DE, Moench TR, Cone RA. Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota. PLoS One. 2013;8(11):e80074. https://doi.org/10.1371/journal.pone.0080074.
4.    France MT, Alizadeh M, Brown S, Ma B, Ravel J. Towards a deeper understanding of the vaginal microbiota. Nat Microbiol. 2022;7(3):367-78. https://doi.org/10.1038/s41564-022-01083-2.
5.    Gajer P, Brotman RM, Bai G, Sakamoto J, Schütte UME, Zhong X, et al. Temporal dynamics of the human vaginal microbiota. Sci Transl Med. 2012;4(132):132ra52. https://doi.org/10.1126/scitranslmed.3003605.
6.    Boskey ER, Telsch KM, Whaley KJ, Moench TR, Cone RA. Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification. Infect Immun. 1999;67(10):5170-5. https://doi.org/10.1128/IAI.67.10.5170-5175.1999.
7.    Holdcroft AM, Ireland DJ, Payne MS. The vaginal microbiome in health and disease—what role do common intimate hygiene practices play? Microorganisms. 2023;11(2):298. https://doi.org/10.3390/microorganisms11020298.
8.    Muzny CA, Balkus J, Mitchell C, Sobel JD, Workowski K, Marrazzo J, et al. Diagnosis and management of bacterial vaginosis: summary of evidence reviewed for the 2021 Centers for Disease Control and Prevention sexually transmitted infections treatment guidelines. Clin Infect Dis. 2022;74 Suppl 2:S144-51. https://doi.org/10.1093/cid/ciac021.
9.    Centers for Disease Control and Prevention. Bacterial vaginosis. In: Sexually transmitted infections treatment guidelines, 2021 [Internet]. Atlanta (GA): CDC; 2021 [cited 2026 Sep 23]. Available from: https://www.cdc.gov/std/treatment-guidelines/bv.htm.
10.Byrne EH, Doherty KE, Bowman BA, Yamamoto HS, Soumillon M, Padavattan N, et al. Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract. Immunity. 2015;42(5):965-76. https://doi.org/10.1016/j.immuni.2015.04.019.
11.Koedooder R, Singer M, Schoenmakers S, Savelkoul PHM, Morré SA, de Jonge JD, et al. The vaginal microbiome as a predictor for outcome of in vitro fertilization with or without intracytoplasmic sperm injection: a prospective study. Hum Reprod. 2019;34(6):1042-54. https://doi.org/10.1093/humrep/dez065.
12.Moreno I, Codoñer FM, Vilella F, Valbuena D, Martinez-Blanch JF, Jimenez-Almazán J, et al. Evidence that the endometrial microbiota has an effect on implantation success or failure. Am J Obstet Gynecol. 2016;215(6):684-703.https://doi.org/10.1016/j.ajog.2016.09.075.
13.Moreno I, Garcia-Grau I, Perez-Villaroya D, Gonzalez-Monfort M, Bahçeci M, Barrionuevo MJ, et al. Endometrial microbiota composition is associated with reproductive outcome in infertile patients. Microbiome. 2022;10(1):1.https://doi.org/10.1186/s40168-021-01184-w.
14.Fettweis JM, Serrano MG, Brooks JP, Edwards DJ, Girerd PH, Parikh HI, et al. The vaginal microbiome and preterm birth. Nat Med. 2019;25(6):1012-21. https://doi.org/10.1038/s41591-019-0450-2.
15.Integrative HMP (iHMP) Research Network Consortium. The Integrative Human Microbiome Project: dynamic analysis of microbiome-host omics profiles during periods of human health and disease. Cell Host Microbe. 2014;16(3):276-89. https://doi.org/10.1016/j.chom.2014.08.014.
16.Wu M, Li H, Yu H, Yan Y, Wang C, Teng F, et al. Disturbances of vaginal microbiome composition in human papillomavirus infection and cervical carcinogenesis: a qualitative systematic review. Front Oncol. 2022;12:941741. https://doi.org/10.3389/fonc.2022.941741.
17.Peng Y, Tang Q, Wu S, Zhao C. Associations of Atopobium, Garderella, Megasphaera, Prevotella, Sneathia, and Streptococcus with human papillomavirus infection, cervical intraepithelial neoplasia, and cancer: a systematic review and meta-analysis. BMC Infect Dis. 2025;25(1):708. https://doi.org/10.1186/s12879-025-10851-4.
18.Colonetti T, Saggioratto MC, Grande AJ, Colonetti L, Junior JCD, Ceretta LB, et al. Gut and vaginal microbiota in endometriosis: systematic review and meta-analysis. Biomed Res Int. 2023;2023:2675966. https://doi.org/10.1155/2023/2675966.
19.Pereira MP, Jones S, Costin JM. Association of polycystic ovarian syndrome (PCOS) with vaginal microbiome dysbiosis: a scoping review. Cureus. 2024;16(6):e62611. https://doi.org/10.7759/cureus.62611
20.Srinivasan S, Morgan MT, Fiedler TL, Djukovic D, Hoffman NG, Raftery D, et al. Metabolic signatures of bacterial vaginosis. mBio. 2015;6(2):e00204-15. https://doi.org/10.1128/mBio.00204-15
21.Vitali B, Cruciani F, Picone G, Parolin C, Donders G, Laghi L. Vaginal microbiome and metabolome highlight specific signatures of bacterial vaginosis. Eur J Clin Microbiol Infect Dis. 2015;34(12):2367-76. https://doi.org/10.1007/s10096-015-2490-y
22.Cohen CR, Wierzbicki MR, French AL, Morris S, Newmann S, Reno H, et al. Randomized trial of Lactin-V to prevent recurrence of bacterial vaginosis. N Engl J Med. 2020;382(20):1906-15. https://doi.org/10.1056/NEJMoa1915254.
23.Lev-Sagie A, Goldman-Wohl D, Cohen Y, Dori-Bachash M, Leshem A, Mor U, et al. Vaginal microbiome transplantation in women with intractable bacterial vaginosis. Nat Med. 2019;25(10):1500-4. https://doi.org/10.1038/s41591-019-0600-6.
24.Vodstrcil LA, Plummer EL, Fairley CK, Hocking JS, Law MG, Petoumenos K, et al. Male-partner treatment to prevent recurrence of bacterial vaginosis. N Engl J Med. 2025;392(10):947-57. https://doi.org/10.1056/NEJMoa2405404.
25.Ma B, Forney LJ, Ravel J. Vaginal microbiome: rethinking health and disease. Annu Rev Microbiol. 2012;66:371-89. https://doi.org/10.1146/annurev-micro-092611-150157.
26.Amabebe E, Anumba DOC. The vaginal microenvironment: the physiologic role of lactobacilli. Front Med (Lausanne). 2018;5:181. https://doi.org/10.3389/fmed.2018.00181.
27.Chee WJY, Chew SY, Than LTL. Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health. Microb Cell Fact. 2020;19(1):203. https://doi.org/10.1186/s12934-020-01464-4.
28.Zheng N, Guo R, Wang J, Zhou W, Ling Z. Contribution of Lactobacillus iners to vaginal health and diseases: a systematic review. Front Cell Infect Microbiol. 2021;11:792787. https://doi.org/10.3389/fcimb.2021.792787.
29.Miller EA, Beasley DE, Dunn RR, Archie EA. Lactobacilli dominance and vaginal pH: why is the human vaginal microbiome unique? Front Microbiol. 2016;7:1936. https://doi.org/10.3389/fmicb.2016.01936.
30.Song SD, Acharya KD, Zhu JE, Deveney CM, Walther-Antonio MRS, Tetel MJ, et al. Daily vaginal microbiota fluctuations associated with natural hormonal cycle, contraceptives, diet, and exercise. mSphere. 2020;5(4):e00593-20. https://doi.org/10.1128/mSphere.00593-20.
31.Romero R, Hassan SS, Gajer P, Tarca AL, Fadrosh DW, Nikita L, et al. The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome. 2014;2:4. https://doi.org/10.1186/2049-2618-2-4.
32.Park MG, Cho S, Oh MM. Menopausal changes in the microbiome—a review focused on the genitourinary microbiome. Diagnostics (Basel). 2023;13(6):1193. https://doi.org/10.3390/diagnostics13061193.
33.Mirmonsef P, Modur S, Burgad D, Gilbert D, Golub ET, French AL, et al. Exploratory comparison of vaginal glycogen and Lactobacillus levels in premenopausal and postmenopausal women. Menopause. 2015;22(7):702-9. https://doi.org/10.1097/GME.0000000000000397
34.Lewis FMT, Bernstein KT, Aral SO. Vaginal microbiome and its relationship to behavior, sexual health, and sexually transmitted diseases. Obstet Gynecol. 2017;129(4):643-54. https://doi.org/10.1097/AOG.0000000000001932.
35.Bakus C, Budge KL, Feigenblum N, Figueroa M, Francis AP. The impact of contraceptives on the vaginal microbiome in the non-pregnant state. Front Microbiomes. 2023;1:1055472. https://doi.org/10.3389/frmbi.2022.1055472.
36.Achilles SL, Austin MN, Meyn LA, Mhlanga F, Chirenje ZM, Hillier SL. Impact of contraceptive initiation on vaginal microbiota. Am J Obstet Gynecol. 2018;218(6):622.e1-622.e10. https://doi.org/10.1016/j.ajog.2018.02.017.
37.Carter KA, Balkus JE, Anzala O, Kimani J, Hoffman NG, Fiedler TL, et al. Associations between vaginal bacteria and bacterial vaginosis signs and symptoms: a comparative study of Kenyan and American women. Front Cell Infect Microbiol. 2022;12:801770. https://doi.org/10.3389/fcimb.2022.801770.
38.France MT, Mendes-Soares H, Forney LJ. Genomic comparisons of Lactobacillus crispatus and Lactobacillus iners reveal potential ecological drivers of community composition in the vagina. Appl Environ Microbiol. 2016;82(24):7063-73. https://doi.org/10.1128/AEM.02385-16.
39.Chen X, Lu Y, Chen T, Li R. The female vaginal microbiome in health and bacterial vaginosis. Front Cell Infect Microbiol. 2021;11:631972. https://doi.org/10.3389/fcimb.2021.631972.
40.Castro J, Machado D, Cerca N. Unveiling the role of Gardnerella vaginalis in polymicrobial bacterial vaginosis biofilms: the impact of other vaginal pathogens living as neighbors. ISME J. 2019;13(5):1306-17. https://doi.org/10.1038/s41396-018-0337-0.
41.McMillan A, Rulisa S, Sumarah M, Macklaim JM, Renaud J, Bisanz J, et al. A multi-platform metabolomics approach identifies novel biomarkers associated with bacterial diversity in the human vagina. arXiv preprint arXiv:150402816; 2015. https://doi.org/10.48550/arXiv.1504.02816.
42.Ponciano JM, Gómez JP, Ravel J, Forney LJ. Inferring stability and persistence in the vaginal microbiome: a stochastic model of ecological dynamics. bioRxiv [Preprint]. 2024. https://doi.org/10.1101/2024.03.02.581600
43.Ma B, France MT, Crabtree J, Holm JB, Humphrys MS, Brotman RM, et al. A comprehensive non-redundant gene catalog reveals extensive within-community intraspecies diversity in the human vagina. Nat Commun. 2020;11(1):940. https://doi.org/10.1038/s41467-020-14677-3
44.France MT, Chaudry I, Rutt L, Quain M, Shirtliff B, McComb E, et al. VIRGO2: an enhanced gene catalog of the vaginal microbiome provides insights into its functional and ecology complexity. Nat Commun. 2026;17(1):449. https://doi.org/10.1038/s41467-025-67136-2.
45.Shah N, Tang H, Doak TG, Ye Y. Comparing bacterial communities inferred from 16S rRNA gene sequencing and shotgun metagenomics. Pac Symp Biocomput. 2011:165-76. https://doi.org/10.1142/9789814335058_0018.
46.Ong SH, Kukkillaya VU, Wilm A, Lay C, Ho EXP, Low L, et al. Species identification and profiling of complex microbial communities using shotgun Illumina sequencing of 16S rRNA amplicon sequences. PLoS One. 2013;8(4):e60811. https://doi.org/10.1371/journal.pone.0060811.
47.Macklaim JM, Fernandes AD, Di Bella JM, Hammond JA, Reid G, Gloor GB. Comparative meta-RNA-seq of the vaginal microbiota and differential expression by Lactobacillus iners in health and dysbiosis. Microbiome. 2013;1(1):12. https://doi.org/10.1186/2049-2618-1-12.
48.France MT, Fu L, Rutt L, Yang H, Humphrys MS, Narina S, et al. Insight into the ecology of vaginal bacteria through integrative analyses of metagenomic and metatranscriptomic data. Genome Biol. 2022;23(1):66. https://doi.org/10.1186/s13059-022-02635-9.
49.Dos Santos SJ, Copeland C, Macklaim JM, Reid G, Gloor GB. Vaginal metatranscriptome meta-analysis reveals functional BV subgroups and novel colonisation strategies. Microbiome. 2024;12(1):271. https://doi.org/10.1186/s40168-024-01992-w.
50.Watson E, Reid G. Metabolomics as a clinical testing method for the diagnosis of vaginal dysbiosis. Am J Reprod Immunol. 2018;80(2):e12979. https://doi.org/10.1111/aji.12979.
51.McMillan A, Rulisa S, Sumarah M, Macklaim JM, Renaud J, Bisanz JE, et al. A multi-platform metabolomics approach identifies highly specific biomarkers of bacterial diversity in the vagina of pregnant and non-pregnant women. Sci Rep. 2015;5:14174. https://doi.org/10.1038/srep14174.
52.Afiuni-Zadeh S, Boylan KLM, Jagtap PD, Griffin TJ, Rudney JD, Peterson ML, et al. Evaluating the potential of residual Pap test fluid as a resource for the metaproteomic analysis of the cervical-vaginal microbiome. Sci Rep. 2018;8(1):10868. https://doi.org/10.1038/s41598-018-29092-4.
53.Aldunate M, Srbinovski D, Hearps AC, Latham CF, Ramsland PA, Gugasyan R, et al. Antimicrobial and immune modulatory effects of lactic acid and short-chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis. Front Physiol. 2015;6:164. https://doi.org/10.3389/fphys.2015.00164.
54.Delgado-Diaz DJ, Tyssen D, Hayward JA, Gugasyan R, Hearps AC, Tachedjian G. Distinct immune responses elicited from cervicovaginal epithelial cells by lactic acid and short-chain fatty acids associated with optimal and non-optimal vaginal microbiota. Front Cell Infect Microbiol. 2020;9:446. https://doi.org/10.3389/fcimb.2019.00446.
55.    Delgado-Diaz DJ, Jesaveluk B, Hayward JA, Tyssen D, Alisoltani A, Potgieter M, et al. Lactic acid from vaginal microbiota enhances cervicovaginal epithelial barrier integrity by promoting tight junction protein expression. Microbiome. 2022;10(1):141. https://doi.org/10.1186/s40168-022-01337-5.
56.Chen L, Li J, Xiao B. The role of sialidases in the pathogenesis of bacterial vaginosis and their use as a promising pharmacological target in bacterial vaginosis. Front Cell Infect Microbiol. 2024;14:1367233. https://doi.org/10.3389/fcimb.2024.1367233.
57.Schwecht I, Nazli A, Gill B, Kaushic C. Lactic acid enhances vaginal epithelial barrier integrity and ameliorates inflammatory effects of dysbiotic short-chain fatty acids and HIV-1. Sci Rep. 2023;13(1):20065. https://doi.org/10.1038/s41598-023-47172-y.
58.Muzny CA, Łaniewski P, Schwebke JR, Herbst-Kralovetz MM. Host-vaginal microbiota interactions in the pathogenesis of bacterial vaginosis. Curr Opin Infect Dis. 2020;33(1):59-65. https://doi.org/10.1097/QCO.0000000000000620.
59.Muzny CA, Sobel JD. The role of antimicrobial resistance in refractory and recurrent bacterial vaginosis and current recommendations for treatment. Antibiotics (Basel). 2022;11(4):500. https://doi.org/10.3390/antibiotics11040500.
60.Shvartsman E, Hill JE, Sandstrom P, MacDonald KS. Gardnerella revisited: species heterogeneity, virulence factors, mucosal immune responses, and contributions to bacterial vaginosis. Infect Immun. 2023;91(5):e00390-22. https://doi.org/10.1128/iai.00390-22.
61.Liang Y, Zhao C, Wen Y, Sheng D, Wei T, Hu T, et al. Modulation of local immunity by the vaginal microbiome is associated with triggering spontaneous preterm birth. Front Immunol. 2024;15:1481611. https://doi.org/10.3389/fimmu.2024.1481611.
62.Van Oostrum N, De Sutter P, Meys J, Verstraelen H. Risks associated with bacterial vaginosis in infertility patients: a systematic review and meta-analysis. Hum Reprod. 2013;28(7):1809-15. https://doi.org/10.1093/humrep/det096.
63.Lokken EM, Manhart LE, Kinuthia J, Hughes JP, Jisuvei C, Mwinyikai K, et al. Association between bacterial vaginosis and fecundability in Kenyan women planning pregnancies: a prospective preconception cohort study. Hum Reprod. 2021;36(5):1279-87. https://doi.org/10.1093/humrep/deab002.
64.Haahr T, Jensen JS, Thomsen L, Duus L, Rygaard K, Humaidan P. Abnormal vaginal microbiota may be associated with poor reproductive outcomes: a prospective study in IVF patients. Hum Reprod. 2016;31(4):795-803. https://doi.org/10.1093/humrep/dew026
65.Singer M, Borg M, Ouburg S, Morré SA. The relation of the vaginal microbiota to early pregnancy development during in vitro fertilization treatment: a meta-analysis. J Gynecol Obstet Hum Reprod. 2019;48(4):223-9. https://doi.org/10.1016/j.jogoh.2019.01.007.
66.Skafte-Holm A, Humaidan P, Bernabeu A, Lledo B, Jensen JS, Haahr T. The association between vaginal dysbiosis and reproductive outcomes in sub-fertile women undergoing IVF treatment: a systematic PRISMA review and meta-analysis. Pathogens. 2021;10(3):295. https://doi.org/10.3390/pathogens10030295.
67.Bernabeu A, Lledo B, Díaz MC, Lozano FM, Ruiz V, Fuentes A, et al. Effect of the vaginal microbiome on the pregnancy rate in women receiving assisted reproductive treatment. J Assist Reprod Genet. 2019;36(10):2111-9. https://doi.org/10.1007/s10815-019-01564-0.
68.Franasiak JM, Werner M, Juneau C, Tao X, Landis J, Zhan Y, et al. Endometrial microbiome at the time of embryo transfer: next-generation sequencing of the 16S ribosomal subunit. J Assist Reprod Genet. 2016;33(1):129-36. https://doi.org/10.1007/s10815-015-0614-z.
69.Moreno I, Simon C. Deciphering the effect of reproductive tract microbiota on human reproduction. Reprod Med Biol. 2019;18(1):40-50. https://doi.org/10.1002/rmb2.12249.
70.Vitale SG, Ferrari F, Ciebiera M, Zgliczyńska M, Rapisarda AMC, Vecchio GM, et al. The role of genital tract microbiome in fertility: a systematic review. Int J Mol Sci. 2022;23(1):180. https://doi.org/10.3390/ijms23010180.
71.Punzón-Jiménez P, Labarta E. The impact of the female genital tract microbiome in women health and reproduction: a review. J Assist Reprod Genet. 2021;38(10):2519-41. https://doi.org/10.1007/s10815-021-02247-5.
72.Samama M, Ueno J, Carvalho de Arruda Veiga E, Piscopo RC, Ikeda F, Pires de Lemos N, et al. Vaginal microbiome and its relationship with assisted reproduction: a systematic review and meta-analysis. Life (Basel). 2025;15(9):1382. https://doi.org/10.3390/life15091382
73.Kindinger LM, Bennett PR, Lee YS, Marchesi JR, Smith A, Cacciatore S, et al. The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk. Microbiome. 2017;5(1):6. https://doi.org/10.1186/s40168-016-0223-9.
74.Bayar E, Bennett PR, Chan D, Sykes L, MacIntyre DA. The pregnancy microbiome and preterm birth. Semin Immunopathol. 2020;42(4):487-99. https://doi.org/10.1007/s00281-020-00817-w.
75.Gerede A, Nikolettos K, Vavoulidis E, Margioula-Siarkou C, Petousis S, Giourga M, et al. Vaginal microbiome and pregnancy complications: a review. J Clin Med. 2024;13(13):3875. https://doi.org/10.3390/jcm13133875.
76.Cobo T, Vergara A, Collado MC, Casals-Pascual C, Herreros E, Bosch J, et al. Characterization of vaginal microbiota in women with preterm labor with intra-amniotic inflammation. Sci Rep. 2019;9(1):18963. https://doi.org/10.1038/s41598-019-55611-y.
77.Sun Z, Ge X, Qiu B, Xiang Z, Jiang C, Wu J, et al. Vulvovaginal candidiasis and vaginal microflora interaction: microflora changes and probiotic therapy. Front Cell Infect Microbiol. 2023;13:1123026. https://doi.org/10.3389/fcimb.2023.1123026.
78.Centers for Disease Control and Prevention. Vulvovaginal candidiasis. In: Sexually transmitted infections treatment guidelines, 2021 [Internet]. Atlanta (GA): CDC; 2021 [cited 2026 Sep 23]. Available from: https://www.cdc.gov/std/treatment-guidelines/candidiasis.htm
79.Sharma H, Tal R, Clark NA, Segars JH. Microbiota and pelvic inflammatory disease. Semin Reprod Med. 2014;32(1):43-9.https://doi.org/10.1055/s-0033-1361822.
80.Centers for Disease Control and Prevention. Pelvic inflammatory disease. In: Sexually transmitted infections treatment guidelines, 2021 [Internet]. Atlanta (GA): CDC; 2021 [cited 2026 Sep 23]. Available from: https://www.cdc.gov/std/treatment-guidelines/pid.htm.
81.Norenhag J, Du J, Olovsson M, Verstraelen H, Engstrand L, Brusselaers N. The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis. BJOG. 2020;127(2):171-80. https://doi.org/10.1111/1471-0528.15854.
82.Mortaki D, Gkegkes ID, Psomiadou V, Blontzos N, Prodromidou A, Lefkopoulos F, et al. Vaginal microbiota and human papillomavirus: a systematic review. J Turk Ger Gynecol Assoc. 2020;21(3):193-200.
https://doi.org/10.4274/jtgga.galenos.2019.2019.0051
83.Mancilla V, Jimenez NR, Bishop NS, Flores M, Herbst-Kralovetz MM. The vaginal microbiota, human papillomavirus infection, and cervical carcinogenesis: a systematic review in the Latina population. J Epidemiol Glob Health. 2024;14(2):480-97. https://doi.org/10.1007/s44197-024-00201-z.
84.Qing X, Xie M, Liu P, Feng O, Leng H, Guo H, et al. Correlation between dysbiosis of vaginal microecology and endometriosis: a systematic review and meta-analysis. PLoS One. 2024;19(7):e0306780. https://doi.org/10.1371/journal.pone.0306780.
85.Gu Y, Zhou G, Zhou F, Li Y, Wu Q, He H, et al. Gut and vaginal microbiomes in PCOS: implications for women’s health. Front Endocrinol (Lausanne). 2022;13:808508. https://doi.org/10.3389/fendo.2022.808508.
86.Chieng WK, Abdul Jalal MI, Bedi JS, Zainuddin AA, Mokhtar MH, Abu MA, et al. Probiotics, a promising therapy to reduce the recurrence of bacterial vaginosis in women? A systematic review and meta-analysis of randomized controlled trials. Front Nutr. 2022;9:938838. https://doi.org/10.3389/fnut.2022.938838.
87.Abbe C, Mitchell CM. Bacterial vaginosis: a review of approaches to treatment and prevention. Front Reprod Health. 2023;5:1100029. https://doi.org/10.3389/frph.2023.1100029.
88.Beck D, Foster JA. Machine learning techniques accurately classify microbial communities by bacterial vaginosis characteristics. PLoS One. 2014;9(2):e87830. https://doi.org/10.1371/journal.pone.0087830.
89.Park S, Moon J, Kang N, Kim YH, You YA, Kwon E, et al. Predicting preterm birth through vaginal microbiota, cervical length, and WBC using a machine learning model. Front Microbiol. 2022;13:912853. https://doi.org/10.3389/fmicb.2022.912853.
90.Golob JL, Oskotsky TT, Tang AS, Roldan A, Chung V, Ha CW, et al. Microbiome preterm birth DREAM challenge: crowdsourcing machine learning approaches to advance preterm birth research. Cell Rep Med. 2024;5(1):101350. https://doi.org/10.1016/j.xcrm.2023.101350.
91.Chakoory O, Barra V, Rochette E, Blanchon L, Sapin V, Merlin E, et al. DeepMPTB: a vaginal microbiome-based deep neural network as artificial intelligence strategy for efficient preterm birth prediction. Biomark Res. 2024;12(1):25. https://doi.org/10.1186/s40364-024-00557-1.
92.Bar O, Vagios S, Barkai O, Elshirbini J, Souter I, Xu J, et al. Harnessing vaginal inflammation and microbiome: a machine learning model for predicting IVF success. NPJ Biofilms Microbiomes. 2025;11(1):95. https://doi.org/10.1038/s41522-025-00732-8.
93.Mirzayi C, Renson A, Genomic Standards Consortium, Massive Analysis and Quality Control Society, Zohra F, Elsafoury S, et al. Reporting guidelines for human microbiome research: the STORMS checklist. Nat Med. 2021;27(11):1885-92.
https://doi.org/10.1038/s41591-021-01552-x
94.O’Callaghan JL, Turner R, Dekker Nitert M, Barrett HL, Clifton V, Pelzer ES. Re-assessing microbiomes in the low-biomass reproductive niche. BJOG. 2020;127(2):147-58. https://doi.org/10.1111/1471-0528.15974.
95.Kennedy KM, de Goffau MC, Perez-Muñoz ME, Arrieta MC, Bäckhed F, Bork P, et al. Questioning the fetal microbiome illustrates pitfalls of low-biomass microbial studies. Nature. 2023;613(7945):639-49. https://doi.org/10.1038/s41586-022-05546-8.
96.Papoutsoglou G, Tarazona S, Lopes MB, Klammsteiner T, Ibrahimi E, Eckenberger J, et al. Machine learning approaches in microbiome research: challenges and best practices. Front Microbiol. 2023;14:1261889. https://doi.org/10.3389/fmicb.2023.1261889.
97.Ling W, Lu J, Zhao N, Lulla A, Plantinga AM, Fu W, et al. Batch effects removal for microbiome data via conditional quantile regression. Nat Commun. 2022;13(1):5418. https://doi.org/10.1038/s41467-022-33071-9.
98.Snell KIE, Archer L, Ensor J, Bonnett LJ, Debray TPA, Phillips B, et al. External validation of clinical prediction models: simulation-based sample size calculations were more reliable than rules-of-thumb. J Clin Epidemiol. 2021;135:79-89. https://doi.org/10.1016/j.jclinepi.2021.02.011
99.McGuire AL, Achenbaum LS, Whitney SN, Slashinski MJ, Versalovic J, Keitel WA, et al. Perspectives on human microbiome research ethics. J Empir Res Hum Res Ethics. 2012;7(3):1-14. https://doi.org/10.1525/jer.2012.7.3.1.
100.Ma Y, Chen H, Lan C, Ren J. Help, hope and hype: ethical considerations of human microbiome research and applications. Protein Cell. 2018;9(5):404-15. https://doi.org/10.1007/s13238-018-0537-4.
101.Chuong KH, Hwang DM, Tullis DE, Waters VJ, Yau YCW, Guttman DS, et al. Navigating social and ethical challenges of biobanking for human microbiome research. BMC Med Ethics. 2017;18(1):1. https://doi.org/10.1186/s12910-016-0160-y.
102.Da Silva AS, Anwar S, Park S, Park S, Goodfellow L, Sergaki C. The untapped potential of vaginal microbiome diagnostics for improving women’s health. Front Cell Infect Microbiol. 2025;15:1595182. https://doi.org/10.3389/fcimb.2025.1595182.